Diagnostic Imaging of Vascular Malformations Using MSOT and ULM
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital Erlangen
About this trial
This clinical study evaluates the efficacy and accuracy of Multispectral Optoacoustic Tomography (MSOT) and Ultrasound Localization Microscopy (ULM) for imaging and diagnosing vascular malformations (venous, arteriovenous, lymphatic). The study aims to enhance diagnostic precision and improve treatment planning through advanced non-invasive imaging techniques.
Eligibility criteria
Qualifiers
Confirmed vascular malformations (arteriovenous, venous, or lymphatic).
≥18 years old and able to give their consent
Disqualifiers
No imaging for diagnostic confirmation has been performed or is planned.
Lack of written consent
<18 years old
Safety concerns of the study physician (a patient with physical, psychological, or psychiatric conditions that, in the opinion of the study physician, could compromise the patient's safety or the quality of the data, thereby making the patient an unsuitable candidate for the study).
Trial design
Treatments tested in this trial
- Multispectral Optoacoustic Tomography
- Ultrasound Localization Microscopy
Treatment groups
15 Participants
are divided into 3 treatment groupsLocations
1University Hospital Erlangen, Department of Vascular Surgery91054, ErlangenBavaria, Germany
Sponsors and collaborators
University Hospital Erlangen
Lead sponsor
PD Dr. med. Ferdinand Knieling, Department of pediatrics, University of Erlangen-Nürnberg
Collaborator
Source ClinicalTrials.gov